Ryan Specialty (NYSE:RYAN) Stock Rating Lowered by Zacks Research

Ryan Specialty (NYSE:RYAN) was downgraded by stock analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a report issued on Tuesday,Zacks.com reports.

Several other brokerages have also recently issued reports on RYAN. Wells Fargo & Company lowered their price target on Ryan Specialty from $63.00 to $56.00 and set an “overweight” rating on the stock in a research report on Friday, February 13th. Barclays decreased their target price on Ryan Specialty from $58.00 to $52.00 and set an “overweight” rating for the company in a research note on Friday, February 13th. Weiss Ratings cut shares of Ryan Specialty from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, February 5th. TD Cowen reissued a “buy” rating on shares of Ryan Specialty in a report on Wednesday, November 26th. Finally, Morgan Stanley reduced their price objective on shares of Ryan Specialty from $61.00 to $55.00 and set an “overweight” rating for the company in a research report on Monday. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $57.47.

Ryan Specialty Stock Performance

Shares of NYSE:RYAN traded up $0.66 on Tuesday, hitting $38.63. The company’s stock had a trading volume of 602,488 shares, compared to its average volume of 2,196,020. The company has a market capitalization of $10.21 billion, a price-to-earnings ratio of 92.09, a price-to-earnings-growth ratio of 1.02 and a beta of 0.62. The company has a debt-to-equity ratio of 2.62, a quick ratio of 0.98 and a current ratio of 0.98. Ryan Specialty has a 12 month low of $37.29 and a 12 month high of $77.16. The stock’s 50-day moving average is $47.95 and its two-hundred day moving average is $52.90.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Thursday, February 12th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.05). The company had revenue of $751.21 million during the quarter, compared to the consensus estimate of $777.43 million. Ryan Specialty had a net margin of 7.02% and a return on equity of 46.41%. The business’s quarterly revenue was up 13.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.45 EPS. On average, equities research analysts forecast that Ryan Specialty will post 2.29 EPS for the current year.

Insider Buying and Selling at Ryan Specialty

In other news, Director Patrick G. Ryan, Jr. purchased 25,500 shares of Ryan Specialty stock in a transaction dated Monday, February 23rd. The stock was acquired at an average cost of $39.96 per share, for a total transaction of $1,018,980.00. Following the acquisition, the director directly owned 428,295 shares in the company, valued at $17,114,668.20. This represents a 6.33% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Timothy William Turner sold 129,570 shares of the business’s stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $53.61, for a total value of $6,946,247.70. Following the completion of the sale, the chief executive officer directly owned 12,553 shares of the company’s stock, valued at approximately $672,966.33. The trade was a 91.17% decrease in their position. The SEC filing for this sale provides additional information. 52.21% of the stock is currently owned by company insiders.

Institutional Trading of Ryan Specialty

A number of institutional investors have recently added to or reduced their stakes in RYAN. Sumitomo Mitsui Trust Group Inc. lifted its position in shares of Ryan Specialty by 2.5% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,387,108 shares of the company’s stock worth $78,177,000 after acquiring an additional 33,588 shares during the period. Cooper Investors PTY Ltd. raised its stake in shares of Ryan Specialty by 33.9% in the third quarter. Cooper Investors PTY Ltd. now owns 505,374 shares of the company’s stock valued at $28,483,000 after purchasing an additional 127,892 shares in the last quarter. Marshall Wace LLP lifted its position in Ryan Specialty by 142.1% in the second quarter. Marshall Wace LLP now owns 380,116 shares of the company’s stock worth $25,844,000 after purchasing an additional 223,124 shares during the period. Waters Parkerson & CO. LLC lifted its position in Ryan Specialty by 4.3% in the third quarter. Waters Parkerson & CO. LLC now owns 508,120 shares of the company’s stock worth $28,638,000 after purchasing an additional 20,920 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in Ryan Specialty by 56.0% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 68,671 shares of the company’s stock worth $3,870,000 after buying an additional 24,656 shares in the last quarter. 84.82% of the stock is currently owned by institutional investors and hedge funds.

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.